SCHEMBL31622671

SCHEMBL31622671

O=C(c1ccc(-c2cc(Cl)c3occc3c2)cc1)N1CC(F)(F)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 3/20 0.39
▸ CDK8 P49336 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CECR2 Q9BXF3 1/20 0.37
▸ PDE4A P27815 2/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ PDE4C Q08493 2/20 0.36
▸ PDE4D Q08499 2/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ PDE5A O76074 1/20 0.36
▸ PDE1A P54750 1/20 0.36
▸ PDE1B Q01064 1/20 0.36
▸ PDE7A Q13946 1/20 0.36
▸ PDE1C Q14123 1/20 0.36
▸ PDE3A Q14432 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31622708 0.89 PDE5A (0.41) ALDH1A1LMNATSHRNPSR1PDE4A
SCHEMBL31622619 0.88 PDE5A (0.38) ALDH1A1LMNATSHRNPSR1PDE4A
SCHEMBL31622622 0.83 HPGD (0.52) ALDH1A1LMNATSHRNPSR1PDE4A
SCHEMBL31622651 0.83 HPGD (0.45) ALDH1A1LMNATSHRNPSR1L3MBTL1
SCHEMBL31622701 0.82 PHGDH (0.53) ALDH1A1JAK2L3MBTL1HPGDMAPK1
SCHEMBL31622669 0.81 L3MBTL1 (0.53) CCNCCDK8ALDH1A1LMNATSHR
SCHEMBL31622694 0.81 POLB (0.56) ALDH1A1LMNATSHRNPSR1PDE4A
SCHEMBL29611926 0.79 PAK4 (0.39) CCNCCDK8CECR2JAK2JAK1
SCHEMBL16344991 0.79 PAK4 (0.39) CCNCCDK8CECR2JAK2JAK1
SCHEMBL18317517 0.77 CCNC (0.38) CCNCCDK8CECR2PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085064-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF KARYOPHARM THERAPEUTICS INC (US) 2026-03-26 — — US disclosed
US-12331040-B2 Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Karyopharm Therapeutics Inc. (US) 2025-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12331040-B2 Substituted benzofuranyl and benzoxazolyl compounds and uses thereof BCL6, MALT1, BTK CCNC 2482/4885CDK8 647/4885ALDH1A1 503/4885
US-20260085064-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF BCL6, MALT1, BCL6B CCNC 1501/4885CDK8 3818/4885ALDH1A1 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback